Literature DB >> 14507334

Anatomically based guidelines for systematic investigation of the central somatosensory system and their application to a spinocerebellar ataxia type 2 (SCA2) patient.

U Rüb1, C Schultz, K Del Tredici, K Gierga, G Reifenberger, R A I de Vos, C Seifried, H Braak, G Auburger.   

Abstract

Dysfunctions of the somatosensory system are among the clinical signs that characterize a variety of polyglutamine or CAG-repeat diseases. Deficits within this system may hinder the perception of potential threats, be detrimental to somatomotor functions, and result in uncoordinated movements, ataxia, and falls. Despite the considerable clinical relevance of such deficits, however, no systematic pathoanatomical studies of the central somatosensory system in polyglutamine diseases are currently available. The present paper has two goals: (1) recommendation of an economical tissue sampling method and optimized histological processing of this tissue to allow rapid and reliable evaluation of the structural integrity of all known relay stations and interconnecting fibre tracts within this complex system, and (2) the proposal of guidelines for a rapid and detailed pathoanatomical investigative procedure of the human central somatosensory system. In so doing, we draw on the current state of neuroanatomic research and apply the methods and guidelines proposed here to a 25-year-old female patient with spinocerebellar ataxia type 2 (SCA2). The use of 100 microm serial sections through the SCA2 patient's central somatosensory components showed that obvious neuronal loss occurred in nearly all of the relay stations of this system (Clarke's column; cuneate, external cuneate and gracile nuclei; spinal, principal and mesencephalic trigeminal nuclei; ventral posterior lateral and ventral posterior medial nuclei of the thalamus), whereas the majority of interconnecting fibre tracts (dorsal spinocerebellar tract; cuneate and gracile fascicles; medial lemniscus; spinal trigeminal tract, trigeminal nerve and mesencephalic trigeminal tract) displayed signs of atrophy accompanied by demyelinization. These pathological findings suffice to explain the patient's impaired senses of vibration, position and temperature. Moreover, together with the lesions seen in the motor cerebellothalamocortical feedback loop (pontine nuclei, deep cerebellar nuclei and cerebellar cortex, ventral lateral nucleus of the thalamus), they also account for the somatomotor deficits that were observed in the young woman (gait, stance, and limb ataxia, falls, and impaired writing). In proposing these new guidelines, we hope to enable others to study the hitherto unknown morphological counterparts of somatosensory dysfunctions in additional CAG-repeat disease patients.

Entities:  

Mesh:

Year:  2003        PMID: 14507334     DOI: 10.1046/j.1365-2990.2003.00504.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  18 in total

1.  Spinocerebellar ataxia type 4 (SCA4): Initial pathoanatomical study reveals widespread cerebellar and brainstem degeneration.

Authors:  Y Hellenbroich; K Gierga; E Reusche; E Schwinger; T Deller; R A I de Vos; C Zühlke; U Rüb
Journal:  J Neural Transm (Vienna)       Date:  2005-12-19       Impact factor: 3.575

2.  Spinocerebellar ataxia type 2 (SCA2): identification of early brain degeneration in one monozygous twin in the initial disease stage.

Authors:  Franziska Hoche; Laszlo Balikó; Wilfred den Dunnen; Katalin Steinecker; Laszlo Bartos; Eniko Sáfrány; Georg Auburger; Thomas Deller; Horst-Werner Korf; Thomas Klockgether; Udo Rüb; Bela Melegh
Journal:  Cerebellum       Date:  2011-06       Impact factor: 3.847

3.  Subject-specific regional measures of water diffusion are associated with impairment in chronic spinal cord injury.

Authors:  Ann S Choe; Cristina L Sadowsky; Seth A Smith; Peter C M van Zijl; James J Pekar; Visar Belegu
Journal:  Neuroradiology       Date:  2017-06-08       Impact factor: 2.804

Review 4.  Spinocerebellar ataxia type 2: clinical presentation, molecular mechanisms, and therapeutic perspectives.

Authors:  J J Magaña; L Velázquez-Pérez; B Cisneros
Journal:  Mol Neurobiol       Date:  2012-09-21       Impact factor: 5.590

5.  Pathoanatomy of cerebellar degeneration in spinocerebellar ataxia type 2 (SCA2) and type 3 (SCA3).

Authors:  W Scherzed; E R Brunt; H Heinsen; R A de Vos; K Seidel; K Bürk; L Schöls; G Auburger; D Del Turco; T Deller; H W Korf; W F den Dunnen; U Rüb
Journal:  Cerebellum       Date:  2012-09       Impact factor: 3.847

6.  Spinocerebellar ataxias types 2 and 3: degeneration of the pre-cerebellar nuclei isolates the three phylogenetically defined regions of the cerebellum.

Authors:  U Rüb; K Gierga; E R Brunt; R A I de Vos; M Bauer; L Schöls; K Bürk; G Auburger; J Bohl; C Schultz; M Vuksic; G J Burbach; H Braak; T Deller
Journal:  J Neural Transm (Vienna)       Date:  2005-03-23       Impact factor: 3.575

Review 7.  Functional neuroanatomy of the human premotor oculomotor brainstem nuclei: insights from postmortem and advanced in vivo imaging studies.

Authors:  Udo Rüb; Joanna C Jen; Heiko Braak; Thomas Deller
Journal:  Exp Brain Res       Date:  2008-04-02       Impact factor: 1.972

8.  Species differences in the expression of Ahi1, a protein implicated in the neurodevelopmental disorder Joubert syndrome, with preferential accumulation to stigmoid bodies.

Authors:  Jennifer E Doering; Kelly Kane; Yi-Chun Hsiao; Cong Yao; Bingxing Shi; Amber D Slowik; Bakul Dhagat; Delisha D Scott; Jeffrey G Ault; Patrick S Page-McCaw; Russell J Ferland
Journal:  J Comp Neurol       Date:  2008-11-10       Impact factor: 3.215

Review 9.  Spinocerebellar ataxia 2 (SCA2).

Authors:  Isabel Lastres-Becker; Udo Rüb; Georg Auburger
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

10.  Cerebellar ataxia, neuropathy, vestibular areflexia syndrome (CANVAS) with chronic cough and preserved muscle stretch reflexes: evidence for selective sparing of afferent Ia fibres.

Authors:  Jon Infante; Antonio García; Karla M Serrano-Cárdenas; Rocío González-Aguado; José Gazulla; Enrique M de Lucas; José Berciano
Journal:  J Neurol       Date:  2018-04-25       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.